Chronic Spontaneous Urticaria (CSU) Study

Adults aged 18 to 75 who have been suffering from chronic spontaneous urticaria (hives), may qualify to participate in this study. To be eligible, participants must have itch and hives present for more than 6 consecutive weeks despite use of antihistamines, have been on daily stable doses of H1 antihistamines prior to the screening visit, and have a CSU diagnosis for 6 months or longer.

Participants will receive investigational oral medication (either active study drug or placebo). Investigational medication will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 14 weeks and include about 8 visits to the study centre, plus 1 telephone visit.

Call the study centre near you or register now.

Learn more about
Hives
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more